Luke Evnin serves as Executive at OSCIENT PHARMACEUTICALS CORP, where they oversee executive responsibilities. Since joining the company, Luke Evnin has executed 203 insider transactions totaling $142.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 19, 2019 involved exercising options for 322,901 shares valued at $0.
Luke Evnin currently holds 2,198,642 shares of OSCIENT PHARMACEUTICALS CORP (OSCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Luke Evnin has been a net seller of OSCI stock. They have purchased $42.8M and sold $99.6M worth of shares.
Luke Evnin's most recent insider trade was on Feb 19, 2019, when they sold 322,901 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $14.00 |
| Discretionary |
| Feb 12, 2019 | HARP | $0 | Conversion | 1,525,164 | $N/A | Discretionary |
| Feb 12, 2019 | HARP | $0 | Conversion | 1,578,751 | $N/A | Discretionary |
| Feb 12, 2019 | HARP | $0 | Conversion | 417,852 | $N/A | Discretionary |
| Feb 12, 2019 | HARP | $21.6K | Exercise | 432,119 | $0.05 | Discretionary |
| Feb 12, 2019 | HARP | $21.3K | Payment | 1,524 | $14.00 | Discretionary |
| Sep 27, 2016 | RDUS | $0 | Other | 1,943,751 | $N/A | Discretionary |
| Mar 8, 2016 | SNDX | $0 | Conversion | 718,396 | $N/A | Discretionary |
| Mar 8, 2016 | SNDX | $0 | Conversion | 312,085 | $N/A | Discretionary |
| Mar 8, 2016 | SNDX | $0 | Conversion | 1,138,210 | $N/A | Discretionary |
| Oct 20, 2015 | CERC | $0 | Conversion | 595,436 | $N/A | Discretionary |
| Jun 6, 2014 | RDUS | $0 | Conversion | 255,881 | $N/A | Discretionary |
| Jun 6, 2014 | RDUS | $0 | Conversion | 714,095 | $N/A | Discretionary |
| Jun 6, 2014 | RDUS | $0 | Other | 1,088,251 | $N/A | Discretionary |
| Jun 6, 2014 | RDUS | $0 | Conversion | 1,929,344 | $N/A | Discretionary |
| Jun 6, 2014 | RDUS | $0 | Conversion | 1,843,682 | $N/A | Discretionary |
| Jan 8, 2014 | ETRM | $711.3K | Sale | 284,531 | $2.50 | Discretionary |
| Jan 8, 2014 | ETRM | $711.3K | Sale | 284,531 | $2.50 | Discretionary |
| Jan 7, 2014 | ETRM | $475.8K | Sale | 190,334 | $2.50 | Discretionary |
| Jan 7, 2014 | ETRM | $475.8K | Sale | 190,334 | $2.50 | Discretionary |
| Jan 6, 2014 | ETRM | $204.3K | Sale | 81,720 | $2.50 | Discretionary |
| Jan 6, 2014 | ETRM | $204.3K | Sale | 81,720 | $2.50 | Discretionary |
| Jun 13, 2013 | PCRX | $610.8K | Sale | 20,311 | $30.07 | Discretionary |
| Jun 12, 2013 | PCRX | $73.0K | Sale | 2,435 | $30.00 | Discretionary |
| Jun 5, 2013 | EPZM | $0 | Conversion | 392,156 | $N/A | Discretionary |
| Jun 5, 2013 | EPZM | $0 | Conversion | 2,309,998 | $N/A | Discretionary |
| Jun 3, 2013 | PCRX | $2.5M | Sale | 82,072 | $30.00 | Discretionary |
| May 31, 2013 | PCRX | $298.1K | Sale | 9,935 | $30.00 | Discretionary |
| May 30, 2013 | PCRX | $1.3M | Sale | 44,582 | $30.00 | Discretionary |